← Back
$ACAD All transactions

ACADIA PHARMACEUTICALS INC

M 10b5-1 Plan

$ Value

$0

Shares

2,596

Price

$0

Filed

May 2

Insider

Name

Kihara James

Title

PRINCIPAL ACCOUNTING OFFICER

CIK

0001816160

Roles

Officer

Transaction Details

Transaction Date

2025-05-01

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

5,192

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. | The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). | The restricted stock units vest in four equal annual installments beginning May 1, 2024.

Filing Info

Accession No.

0001415889-25-011875

Form Type

4

Issuer CIK

0001070494

Kihara James's History

Date Ticker Type Value
2026-04-07 ACAD $23K
2026-04-05 ACAD M
2026-04-05 ACAD M $0
2026-03-26 ACAD $24K
2026-03-26 ACAD $261
2026-03-25 ACAD $18K
2026-03-25 ACAD M
2026-03-25 ACAD M $0
2026-03-24 ACAD M
2026-03-24 ACAD M $0

Other Insiders at ACAD (90d)

Insider Bought Sold Last
Rhodes Jennifer J
EVP, CHIEF LEGAL OFFICER, SEC
$83K 2026-03-25
Kihara James
PRINCIPAL ACCOUNTING OFFICER
$65K 2026-04-07
Owen Adams Catherine
Chief Executive Officer
$250K 2026-03-25
Thompson Elizabeth H.Z.
EVP, Head of Research & Dev
$74K 2026-03-25
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
$219K 2026-04-07